Your browser doesn't support javascript.
loading
Exploring the influence of smoking and alcohol consumption on clinical severity in patients with facioscapulohumeral muscular dystrophy.
Vincenten, Sanne C C; Mul, Karlien; Schreuder, Tim H A; Voermans, Nicol C; Horlings, Corinne G C; van Engelen, Baziel G M.
Affiliation
  • Vincenten SCC; Department of Neurology, Donders Institute for Brain, Cognition and Behavior, Radboud University Medical Center, PO Box 9101, 6500 HB Nijmegen, the Netherlands. Electronic address: Sanne.vincenten@radboudumc.nl.
  • Mul K; Department of Neurology, Donders Institute for Brain, Cognition and Behavior, Radboud University Medical Center, PO Box 9101, 6500 HB Nijmegen, the Netherlands.
  • Schreuder THA; Department of Neurology, Donders Institute for Brain, Cognition and Behavior, Radboud University Medical Center, PO Box 9101, 6500 HB Nijmegen, the Netherlands.
  • Voermans NC; Department of Neurology, Donders Institute for Brain, Cognition and Behavior, Radboud University Medical Center, PO Box 9101, 6500 HB Nijmegen, the Netherlands.
  • Horlings CGC; Department of Neurology, Maastricht University Medical Centre School of Mental Health and Neuroscience, Maastricht, the Netherlands.
  • van Engelen BGM; Department of Neurology, Donders Institute for Brain, Cognition and Behavior, Radboud University Medical Center, PO Box 9101, 6500 HB Nijmegen, the Netherlands.
Neuromuscul Disord ; 31(9): 824-828, 2021 09.
Article de En | MEDLINE | ID: mdl-34407911
ABSTRACT
Despite the growing knowledge on the (epi)genetic background of facioscapulohumeral muscular dystrophy (FSHD), the substantial variability in disease severity that exists between FSHD patients is not fully understood. We hypothesized that smoking and alcohol consumption are disease modifiers in FSHD and contribute to the variability in disease severity, because they are both associated with higher levels of oxidative stress in muscle tissue. Oxidative stress is known to influence FSHD muscle tissue. One hundred and ninety-eight genetically confirmed FSHD patients completed a questionnaire from which the number of packyears of smoking and the lifetime cumulative alcohol units consumed were calculated. Disease severity was determined by the FSDH evaluation score. Multiple linear regression analyses showed that both the number of packyears and the amount of alcohol consumption did not influence disease severity (respectively B = 0.025, ΔR2=0.006, p = 0.231; and B = 0.000, ΔR2=0.004, p = 0.406). Although smoking and excessive alcohol consumption are unhealthy habits which should be discouraged, these results show that smoking and alcohol consumption have no clinically meaningful modifying effect on disease severity in FSHD patients. However, prospective data should show whether alcohol consumption and smoking influence disease progression rate.
Sujet(s)
Mots clés

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Consommation d'alcool / Fumer / Dystrophie musculaire facio-scapulo-humérale Type d'étude: Etiology_studies / Incidence_studies / Observational_studies / Prevalence_studies / Risk_factors_studies Limites: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Pays/Région comme sujet: Europa Langue: En Journal: Neuromuscul Disord Sujet du journal: NEUROLOGIA Année: 2021 Type de document: Article

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Consommation d'alcool / Fumer / Dystrophie musculaire facio-scapulo-humérale Type d'étude: Etiology_studies / Incidence_studies / Observational_studies / Prevalence_studies / Risk_factors_studies Limites: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Pays/Région comme sujet: Europa Langue: En Journal: Neuromuscul Disord Sujet du journal: NEUROLOGIA Année: 2021 Type de document: Article